MCL1 and plasma cell myeloma: Some myeloma cells resist immune-mediated cytotoxicity through intrinsic mechanisms involving the upregulation of anti-apoptotic proteins such as B cell lymphoma 2 (BCL-2), myeloid cell leukemia 1 (MCL-1), and B cell lymphoma-extra-large (BCL-XL).